EP2717847A2 - Produit de coiffage sans effet alourdissant - Google Patents

Produit de coiffage sans effet alourdissant

Info

Publication number
EP2717847A2
EP2717847A2 EP12724336.8A EP12724336A EP2717847A2 EP 2717847 A2 EP2717847 A2 EP 2717847A2 EP 12724336 A EP12724336 A EP 12724336A EP 2717847 A2 EP2717847 A2 EP 2717847A2
Authority
EP
European Patent Office
Prior art keywords
hair
weight
copolymer
wax
polymers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP12724336.8A
Other languages
German (de)
English (en)
Inventor
Thorsten Knappe
Julia Bibiane LANGE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP2717847A2 publication Critical patent/EP2717847A2/fr
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8182Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/927Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/06Preparations for styling the hair, e.g. by temporary shaping or colouring

Definitions

  • the present invention relates to means for the temporary deformation of keratinous fibers, comprising a combination of at least one specific polymer with other specific ingredients, the use of these means for the temporary deformation of keratinous fibers and a corresponding method.
  • keratinic fibers in principle, all animal hair, e.g. Wool, horsehair, angora hair, furs, feathers and products or textiles made from them.
  • animal hair e.g. Wool, horsehair, angora hair, furs, feathers and products or textiles made from them.
  • the keratinic fibers are human hairs.
  • Corresponding temporary shaping agents usually contain synthetic polymers as the shaping component.
  • Preparations containing a dissolved or dispersed polymer can be applied to the hair by means of propellant gases or by a pumping mechanism.
  • hair gels and hair waxes are generally not applied directly to the hair, but distributed by means of a comb or hands in the hair.
  • the most important property of a composition for the temporary deformation of keratinic fibers is to give the treated fibers in the produced form the strongest possible hold. If the keratin fibers are human hair, it is also referred to as a strong hairstyle or the high degree of retention of the styling agent.
  • the hairstyle hold is essentially determined by the type and amount of the synthetic polymer used, but also an influence of the other constituents of the styling agent may be given.
  • Object of the present invention was therefore to provide a means for temporary deformation of keratinous fibers available, which is characterized by a very high degree of hold without the need for remodeling, a neat hair feel and shine and pleasant product feel should be avoided.
  • a first subject of the present invention is therefore a cosmetic agent containing in a cosmetically acceptable carrier, in each case based on its weight
  • compositions according to the invention contain as the first compulsory component a polymer which is made up of at least two different monomers of the formulas (I) and (II). In addition, other monomers may be copolymerized.
  • the first monomer contained in copolymer A is sodium acrylate, i. the sodium salt of acrylic acid.
  • acrylic acid may also be present as a further monomer unit in the polymers, but this is not absolutely necessary according to the invention.
  • the second monomer contained in Copolymer A is 2-methyl-2 [(1-oxo-2-propenyl) amino] -1-propanesulfonic acid (AMPS), which may be partially or fully neutralized. Usually, Na + and NH 4 + are preferred as cations.
  • the monomers of formulas (I) and (II) are preferably included in the copolymers A in such number and distribution that the copolymer A has molecular weights between 5 and 1000 kDa.
  • Preferred agents according to the invention are characterized in that they contain copolymer (e) A having molecular weights of from 10 to 750 kDa, preferably from 25 to 500 kDa, more preferably from 50 to 400 kDa and in particular from 70 to 250 kDa.
  • the monomers of the formulas (I) and (II) are contained within certain limits in the copolymer A.
  • preferred agents according to the invention characterized in that they contain copolymer (e) A, the
  • compositions according to the invention contain one or more copolymers A, it is preferred to use the copolymers A within certain quantitative ranges.
  • agents according to the invention are preferred which, based on the weight of the ready-to-use agent, 0.025 to 2.5 wt .-%, preferably 0.05 to 2 wt .-% and in particular 0, 1 to 1 wt .-% copolymer (e ) A included.
  • copolymers A are partially or completely neutralized, crosslinked copolymers of 2-methyl-2 [(1-oxo-2-propenyl) amino] -1-propanesulfonic acid (AMPS) and acrylic acid.
  • AMPS 2-methyl-2 [(1-oxo-2-propenyl) amino] -1-propanesulfonic acid
  • acrylic acid acrylic acid
  • AMPS 2-methyl-2 [(1-oxo-2-propenyl) amino] -1-propanesulfonic acid
  • acrylic acid or sodium acrylate acrylic acid or sodium acrylate
  • dimethylacrylamide in the form of an inverse, auto-inversible latex commercially available, for. B. under the trade name Simulgel ® SMS 88 from Seppic.
  • copolymers A contained in the agents according to the invention may contain, in addition to the monomers (I) and (II), further monomers.
  • Copolymers A which contain at least one structural unit of the formula (I) and at least one structural unit of the formula (II) and at least one structural unit of the formula (III) have proven particularly useful
  • the third monomer contained in the copolymer A is dimethylacrylamide.
  • the copolymers A of this preferred embodiment can be characterized by the general formula
  • the monomers of formulas (I), (II) and (III) are preferably included in the copolymers A of this preferred embodiment in such number and distribution that the copolymer A of this preferred embodiment has molecular weights between 5 and 1000 kDa.
  • the monomers of the formulas (I), (II) and (III) are contained within certain limits in the copolymer A.
  • agents of this preferred embodiment according to the invention are characterized in that they contain copolymer (e) A, the
  • the agents according to the invention contain.
  • the agents according to the invention contain from 0.05 to 10% by weight, preferably from 0.1 to 7.5% by weight, more preferably from 0.25 to 6% by weight and in particular from 0.5 to 5% by weight .-% of at least one film-forming polymer.
  • film-forming and / or setting polymers may be included. These film-forming and / or setting polymers may be both permanent and temporary cationic, anionic, nonionic or amphoteric. Of course, when using at least two film-forming and / or setting polymers, they may have different charges. It may be preferred according to the invention for an ionic film-forming and / or setting polymer to be used together with an amphoteric and / or nonionic film-forming and / or setting polymer. The use of at least two oppositely charged film-forming and / or setting polymers is also preferred. In the latter case, a particular embodiment may in turn additionally contain at least one further amphoteric and / or nonionic film-forming and / or setting polymer.
  • Film-forming polymers are polymers which leave a continuous film on the skin, the hair or the nails when drying.
  • Such film formers can be used in a wide variety of cosmetic products, such as for example face masks, make-up, hair fixatives, hair sprays, hair gels, hair waxes, hair treatments, shampoos or nail varnishes.
  • Particularly preferred are those polymers which have sufficient solubility in water, alcohol or water / alcohol mixtures. This makes it possible to produce appropriate solutions that can be applied or processed in a simple manner.
  • the film-forming polymers may be of synthetic or natural origin.
  • Film-forming polymers furthermore include those polymers which, when used in 0.01 to 20% strength by weight aqueous, alcoholic or aqueous-alcoholic solution, are capable of depositing a transparent polymer film on the hair.
  • the film-forming polymers may be anionic, amphoteric, nonionic, permanent cationic or temporarily cationically charged.
  • Suitable and inventively preferably used synthetic film-forming, hair-fixing polymers are homopolymers or copolymers which are composed of at least one of the following monomers: vinyl pyrrolidone, vinylcaprolactam, vinyl esters such as vinyl acetate, vinyl alcohol, acrylamide, methacrylamide, C to C 7 alkylacrylamide , C 1 to C 7 dialkylacrylamide, C 1 to C 7 - Alkylmethacrylamide, C 1 -C 7 -dialkylmethacrylamide, C 1 -C 7 -alkyl acrylate, acrylic acid, propylene glycol, ethylene glycol, where the C 1 -C 7 -alkyl groups of these monomers are preferably C 1 -C 3 -alkyl groups.
  • Examples include homopolymers of vinylcaprolactam, vinylpyrrolidone or N-vinylformamide.
  • Further suitable synthetic film-forming, hair-fixing polymers are copolymers of vinyl pyrrolidone and vinyl acetate, terpolymers of vinylpyrrolidone, vinyl acetate and vinyl propionate, polyacrylamides, for example, under the trade designations Akypomine ® P 191 by the company CHEM-Y, Emmerich or Sepigel ® 305 by the company Seppic be distributed; Polyvinyl alcohols, which are marketed under the trade names Elvanol.RTM ® from DuPont or Vinol ® 523/540 by Air Products as well as polyethylene glycol / polypropylene glycol copolymers, for example, Ucon ® Union Carbide sold under the trade names.
  • Suitable natural film-forming polymers include cellulose derivatives, eg. B. hydroxypropyl cellulose having a molecular weight of 30,000 to 50,000 g / mol, which is sold for example under the trade name Nisso Sl ® from Lehmann & Voss, Hamburg.
  • Firming polymers contribute to the maintenance and / or build-up of the hair volume and hair fullness of the overall hairstyle.
  • setting polymers are at the same time film-forming polymers and therefore generally typical substances for shaping hair treatment compositions such as hair fixatives, hair foams, hair waxes, hair sprays.
  • the film formation can be quite selective and connect only a few fibers.
  • Substances which further impart hydrophobic properties to the hair are preferred because they reduce the tendency of the hair to absorb moisture, that is, water. As a result, the limp drooping of the strands of hair is reduced, thus ensuring a long-lasting hairstyle structure and preservation.
  • the test method for this is often the so-called curl retention test applied.
  • These polymeric substances can also be successfully incorporated into leave-on and rinse-off hair treatments or shampoos. Since polymers are often multifunctional, that is, show several applications-wise desirable effects, numerous polymers can be found in several groups divided according to the particular mode of action, as well as in the CTFA Handbook. Because of the importance of polymers in particular, they should therefore be listed explicitly in the form of their INCI names.
  • Examples of common film-forming, setting polymers are Acrylamide / Ammonium Acrylate Copolymer, Acrylamide / DMAPA Acrylates / Methoxy PEG Methacrylate Copolymer, Acrylamidopropyltrimonium Chloride / Acrylamide Copolymer, Acrylamidopropyltrimonium Chloride / Acrylates Copolymer, Acrylates / Acetoacetoxyethyl Methacrylate Copolymer, Acrylates / Acrylamide Copolymer, Acrylates / Ammonium Methacrylate Copolymer, Acrylates / t-Butyl Acrylamide Copolymer, Acrylates Copolymer, Acrylates / CI-2 Succinates / Hydroxy Acrylates Copolymer, Acrylates / Lauryl Acrylates / Stearyl Acrylates / Ethylamine Oxide Methacryl
  • compositions according to the invention contain at least one film-forming and / or setting polymer composed of vinylpyrrolidone-vinyl acetate copolymers, vinyl acetate-crotonic acid copolymers, vinylcaprolactam-vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers, octylacrylamide-acrylate-butylaminoethyl methacrylate copolymers and quaternized vinylpyrrolidone-dimethylaminoethyl methacrylate copolymers.
  • Copolymer is selected.
  • the film-forming and / or setting the polymer to the vinylpyrrolidone-vinyl acetate copolymers Luviskol ® VA 37, or PVP / VA Copolymer 60/40 W NP, the vinyl acetate-crotonic acid copolymers, sold under the trade name Aristoflex ® A 60 is sold, the caprolactam-vinylpyrrolidone-dimethylaminoethyl methacrylate copolymer with tradename Advantage ® LC-e, that available under the name Amphomer ® amphoteric octylacrylamide-acrylate-butylaminoethyl-methacrylate copolymer or quaternized by reaction with diethyl sulfate, vinylpyrrolidone-dimethylaminoethyl copoly- which is sold under the trade name Gafquat ® 755N mer.
  • compositions according to the invention additionally contain at least one vinylpyrrolidone-vinyl acetate copolymer.
  • agents according to the invention are preferred in which the film-forming and / or hair-fixing polymer is selected from at least one polymer selected from nonionic polymers based on ethylenically unsaturated monomers, nonionic cellulose derivatives, starch and its derivatives, chitosan and Derivatives of chitosan, cationic cellulose derivatives, cationic copolymers of 3- (C 1 -C 6 ) -alkyl-1-vinyl-imidazolinium, homopolymers and copolymers of diallyldimethylammonium, homopolymers and copolymers containing the structural unit of the formula (M-1)
  • R 2 -H or -CH 3
  • R 3, R 4 and R 5 are independently selected from (Ci -C 4) alkyl, (Ci to C4) -alkenyl or (C 2 to C 4) hydroxyalkyl
  • p 1, 2, 3 or 4
  • q is a natural number
  • the agents according to the invention contain 0.5 to 30 wt .-%, preferably 1 to 25 wt .-%, more preferably 2.5 to 20 wt .-% and in particular 5 to 15 wt .-% of at least one wax having a melting point in a range of 40 ° C to 90 ° C.
  • waxes are of solid to brittle hard consistency, coarse to fine crystalline, translucent to opaque, but not glassy, and melt above 40 ° C without decomposition. They are already slightly above the melting point low viscosity and show a strong temperature-dependent consistency and solubility.
  • Preference according to the invention for example, natural vegetable waxes, z.
  • montan ester waxes hydrogenated jojoba waxes and Sasol waxes used.
  • Synthetic waxes which are also preferable in the invention include, for example, polyalkylene waxes, especially polyethylene waxes, and polyethylene glycol, C 2 ° C 40 dialkyl esters of dimer acids, C 30 -5o-alkyl and alkylaryl esters of Alkylbienenwachs and dimer fatty acids.
  • a particularly preferred wax component is selected from at least one ester of a saturated, monohydric C 6 -C 50 -alcohol and a saturated C 8 -C 36 -monocarboxylic acid.
  • ester of a saturated, monohydric C 6 -C 50 -alcohol and a saturated C 8 -C 36 -monocarboxylic acid for this purpose also include lactides, the cyclic double esters of ⁇ -hydroxycarboxylic acids of the corresponding chain length.
  • Esters of fatty acids and long-chain alcohols have proved to be particularly advantageous for the inventively preferred compositions.
  • the esters are composed of saturated, branched or unbranched monocarboxylic acids and saturated, branched or unbranched monohydric alcohols.
  • Esters of aromatic carboxylic acids or hydroxycarboxylic acids (eg 12-hydroxystearic acid) and saturated, branched or unbranched alcohols can also be used according to the invention, provided that the wax component has a melting point> 50 ° C. It is particularly preferred to choose the wax components from the group of esters saturated, branched or unbranched alkanecarboxylic acids of a chain length of 12 to 24 carbon atoms and the saturated, branched or unbranched alcohols of a chain length of 16 to 50 carbon atoms, which have a melting point> 50 ° C.
  • a wax component C 16 . 36 alkyl stearates and C 18 to C 38 alkylhydroxystearoyl stearates C 2 o ⁇ o-alkyl erucates and Cetearylbehenat be preferred.
  • the wax or the wax components have a melting point> 50 ° C, preferably> 60 ° C, on.
  • a particularly preferred embodiment of the invention contains as wax component a C 2 o-C 40 alkyl stearate. This ester is known under the name Kester ® K82H or Kesterwachs ® K80H and is sold by Koster Keunen Inc..
  • a further particularly preferred embodiment of the invention contains as wax component cetearyl behenate, ie mixtures of cetyl behenate and stearyl behenate. This ester is known under the name Kester ® K62 and is sold by Koster Keunen Inc..
  • wax components with a melting point> 50 ° C are the triglycerides of saturated and optionally hydroxylated C 12-3o fatty acids, such as hardened triglyceride fats (hydrogenated palm oil, hydrogenated coconut oil, hydrogenated castor oil), glyceryl tribehenate (tribehenin) or glyceryl tri-12-hydroxystearate, furthermore synthetic Full esters of fatty acids and glycols or polyols having 2-6 carbon atoms, as long as they have a melting point above 50 ° C, for example, preferably Ci 8 -C 38 Acid triglycerides (Syncrowax ® HGL-C).
  • hydrogenated castor oil obtainable, for example, as wax component is available.
  • Cutina ® HR particularly preferred.
  • lipid or wax components having a melting point> 50 ° C are the saturated linear C 4 -C 36 carboxylic acids, in particular myristic acid, palmitic acid, stearic acid and behenic acid and mixtures of these compounds, for.
  • lipid or wax components with a melting point in the range of 30- 150 ° C are linear, saturated C. 8 30- fatty acids.
  • Preferred are linear, saturated Cio-22 fatty acids.
  • Preferred fatty acids are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, elaeostearic, arachidonic, gadoleic, behenic and erucic acid, and technical mixtures thereof.
  • Particularly preferred is the use of stearic acid.
  • the fatty acids used can carry one or more hydroxyl groups. Preferred examples of these are the ⁇ -hydroxy C 8 -C 18 carboxylic acids and 12-hydroxystearic acid.
  • lipid or wax components having a melting point in the range of 30-150 ° C are fatty alcohols.
  • fatty alcohols it is possible to use saturated, unbranched fatty alcohols having 6-30, preferably 10-22 and very particularly preferably 12-22 carbon atoms.
  • Applicable for the purposes of the invention are z. Decanol, octanol, eruca alcohol, ricinol alcohol, 12- Hydroxystearyl alcohol, stearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol and behenyl alcohol.
  • compositions according to the invention are characterized in that the wax component is selected from esters of a saturated, monohydric C 16 -C 60 alkanol and a saturated C 6 -C 3 6-monocarboxylic acid, in particular cetyl behenate, stearyl behenate and C 2 ° C 40 alkyl, Glycerintriestern of saturated linear C 2 -C 30 carboxylic acids which may be hydroxylated, candelilla wax, carnauba wax, beeswax, saturated linear C 4 -C 36 carboxylic acids and mixtures of the aforementioned substances.
  • the wax component is selected from esters of a saturated, monohydric C 16 -C 60 alkanol and a saturated C 6 -C 3 6-monocarboxylic acid, in particular cetyl behenate, stearyl behenate and C 2 ° C 40 alkyl, Glycerintriestern of saturated linear C 2 -C 30 carboxylic acids which may be hydroxylated, candeli
  • Particularly preferred wax component blends are selected from mixtures of cetyl behenate, stearyl behenate, hardened castor oil, palmitic acid and stearic acid. Further particularly preferred wax component mixtures are selected from mixtures of C 2 ° C 40 - alkyl stearate, hardened castor oil, palmitic acid and stearic acid.
  • compositions according to the invention are characterized in that the wax component is selected from mixtures of esters of a saturated monohydric C 6 -C 6 o-alkanol and a saturated C 8 -C 36 monocarboxylic acid, in particular C 2 ° C 40 - alkyl stearate, glycerol triesters saturated linear C 2 -C 30 -carboxylic acids which may be hydroxylated, in particular hydrogenated castor oil, and saturated linear C 4 -C 36 -carboxylic acids, in particular palmitic acid and stearic acid.
  • the wax component is selected from mixtures of esters of a saturated monohydric C 6 -C 6 o-alkanol and a saturated C 8 -C 36 monocarboxylic acid, in particular C 2 ° C 40 - alkyl stearate, glycerol triesters saturated linear C 2 -C 30 -carboxylic acids which may be hydroxylated, in particular hydrogenated castor oil, and
  • particularly preferred agents according to the invention are characterized in that they contain at least one wax from the group of beeswax, carnauba wax, candelilla wax, montan wax, cetyl palmitate or mixtures thereof.
  • compositions of the invention contain the ingredients in a cosmetically acceptable carrier.
  • Preferred cosmetically acceptable carriers are aqueous, alcoholic or aqueous-alcoholic media with preferably at least 10% by weight of water, based on the total agent.
  • alcohols it is possible in particular to include the lower alcohols having 1 to 4 carbon atoms usually used for cosmetic purposes, such as, for example, ethanol and isopropanol.
  • organic solvents or a mixture of solvents having a boiling point below 400 ° C in an amount of 0, 1 to 15 weight percent, preferably from 1 to 10 weight percent based on the total agent may be included.
  • Particularly suitable as additional co-solvents are unbranched or branched hydrocarbons such as pentane, hexane, isopentane and cyclic hydrocarbons such as cyclopentane and cyclohexane.
  • particularly preferred water-soluble solvents are glycerol, ethylene glycol, butylene glycol and propylene glycol in an amount of up to 30 wt .-% based on the total agent.
  • Very particularly preferred agents according to the invention are highly hydrous. It has been found that the adjustment of gloss, remodulability and degree of retention in the compositions according to the invention is particularly successful when they contain high amounts of water. Particularly preferred agents according to the invention are therefore characterized in that, based on their weight, they contain 40 to 95% by weight, preferably 45 to 92.5% by weight, more preferably 50% to 90 wt .-%, more preferably 55 to 87.5 wt .-% and in particular 60 to 85 wt .-% water.
  • compositions of the invention can be further increased by the use of small amounts of one or more polyhydric alcohols.
  • Preferred agents according to the invention contain, based on their weight, 0.25 to 5% by weight, preferably 0.5 to 4% by weight, more preferably 0.75 to 3% by weight and in particular 1 to 2.5% by weight.
  • the agents preferably have a pH of 2 to 1 1.
  • the pH range between 4 and 9 is particularly preferred.
  • the information on the pH value in the context of this document refers to the pH at 25 ° C., unless stated otherwise.
  • compositions of the invention may further contain the auxiliaries and additives which are usually added to the respective cosmetic products.
  • auxiliaries and additives are care substances. These are used both in skin and hair treatment application and can be incorporated with a suitable choice of the care substance, for example in creams, shampoos, hair conditioners, hair treatments, gels, pump and aerosol sprays and show m.
  • an agent according to the invention may contain, for example, at least one protein hydrolyzate and / or one of its derivatives.
  • Protein hydrolysates are product mixtures obtained by acid, alkaline or enzymatically catalyzed degradation of proteins (proteins).
  • the molecular weight of the protein hydrolysates which can be used according to the invention is between 75, the molecular weight for glycine, and 200,000, preferably the molecular weight is 75 to 50,000 and very particularly preferably 75 to 20,000 daltons.
  • protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin, silk and milk protein protein hydrolysates, which may also be present in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois® ® (Interorgana) Collapuron ® (Cognis), Nutrilan® ® (Cognis), Gelita-Sol ® (German Gelatinefabriken Stoess & Co), Lexein ® (Inolex) sericin (Pentapharm) and kerasol tm ® (Croda) sold.
  • the protein hydrolysates are present in the agents according to the invention, for example, in concentrations of from 0.01% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and very particularly preferably in amounts of 0 , 05 wt .-% up to 5 wt .-%, each based on the total application preparation included.
  • Cationic surfactants of the quaternary ammonium compounds, esterquats and amidoamines type are preferred according to the invention.
  • Preferred quaternary ammonium compounds are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, for example cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, lauryldimethylammonium chloride, lauryldimethylbenzylammonium chloride and tricetylmethylammonium chloride, and the imidazolium known under the INCI names Quaternium-27 and Quaternium-83 -Links.
  • esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element.
  • Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
  • Such products are marketed under the trade names Stepantex® ®, ® and Dehyquart® Armocare® ®.
  • the products Armocare ® VGH-70, a N, N-bis (2-palmitoyloxyethyl) dimethylammonium chloride, as well as Dehyquart ® F-75, Dehyquart ® C-4046, Dehyquart ® L80 and Dehyquart ® AU-35 are examples of such esterquats.
  • the alkylamidoamines are usually prepared by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines.
  • An inventively particularly suitable compound from this group of substances under the name Tegoamid ® S 18 commercial stearamidopropyl dimethylamine is.
  • the cationic surfactants are contained in the compositions according to the invention preferably in amounts of from 0.05 to 10% by weight, based on the total application preparation. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • Nurturing polymers are also suitable as a care substance. It should be noted at this point that some nourishing polymers also have film-forming and / or setting properties, and may therefore also be mentioned in the list of suitable film-forming and / or setting polymers.
  • a first group of caring polymers are the cationic polymers.
  • Cationic polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be “temporary” or “permanent” cationic.
  • “permanently cationic” refers to those polymers which have a cationic group, irrespective of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group. Preferred cationic groups are quaternary ammonium groups.
  • R -H or -CH 3
  • R 2, R 3 and R 4 are independently selected from CI_ 4 -alkyl, -alkenyl or -hydroxyalkyl groups
  • m 1, 2, 3 or 4
  • n is an natural number
  • X is a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the monomer units listed in formula (G1-I) and nonionic monomer units, are particularly preferred cationic polymers preferably, for which at least one of the following conditions applies: R is a methyl group, R 2 , R 3 and R 4 are methyl groups, m has the value 2.
  • Suitable physiologically tolerable counterions X " include, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions, preference being given to halide ions, in particular chloride.
  • a particularly suitable homopolymer is, if desired, crosslinked, poly (meth acryloyloxyethyltrimethylammonium chloride) with the INCI name Polyquaternium-37.
  • the crosslinking can be carried out with the aid of poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose.
  • Methylenebisacrylamide is a preferred crosslinking agent.
  • the homopolymer is preferably used in the form of a non-aqueous polymer dispersion which should not have a polymer content of less than 30% by weight.
  • Such polymer dispersions are (under the names Salcare ® SC 95 about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl-polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1 trideceth-6) ) and Salcare ® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol (with a mixture of caprylic and capric acid INCI name: propylene glycol Dicaprylate / Dicaprate) and tridecyl polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-1-Trideceth-6)) commercially available.
  • Copolymers contain monomer units having the formula (G1-I) as a non-ionic monomer, preferably acrylamide, methacrylamide, acrylic acid and methacrylic acid alkyl esters CI_ 4 d-4-alkyl ester. Among these nonionic monomers, the acrylamide is particularly preferred. These copolymers can also be crosslinked, as described above in the case of the homopolymers. A copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer. Such copolymers in which the monomers in a Weight ratio of about 20:80 are commercially available as about 50% non-aqueous polymer dispersion under the name Salcare ® SC 92 available.
  • Celquat ® quaternized cellulose derivatives, such as are available under the names of Celquat ® and Polymer JR ® commercially.
  • JR® 400 are preferred quaternized cellulose derivatives
  • honey for example the commercial product Honeyquat ® 50,
  • cationic guar derivatives in particular those sold under the tradename Cosmedia Guar ® and Jaguar ® products,
  • Quaternary group polysiloxanes such as the commercially available products Q2-7224 (manufactured by Dow Corning, a stabilized trimethylsilylamodimethicone), Dow Corning® 929 emulsion (containing a hydroxylamino-modified silicone, also referred to as amodimethicones), SM -2059 (manufacturer: General Electric), SLM-55067 (manufacturer: Wacker) and Abil ® quat 3270 and 3272 (manufacturer: Th Goldschmidt.), diquaternary polydimethylsiloxanes, quaternium-80)
  • Polyquaternium 2 Polyquaternium 17, Polyquaternium 18 and Polyquaternium 27 with quaternary nitrogen atoms in the polymer main chain.
  • cationic polymers which can be used according to the invention are the so-called "temporary cationic" polymers. These polymers usually contain an amino group which, at certain pH values, is present as quaternary ammonium group and thus cationic.
  • temporary cationic polymers usually contain an amino group which, at certain pH values, is present as quaternary ammonium group and thus cationic.
  • chitosan and its derivatives are preferred as Hydagen CMF ®, Hydagen HCMF ®, Kytamer ® PC and Chitolam ® NB / 101 are freely available commercially, for example under the trade names.
  • the agents according to the invention preferably contain the caring, cationic and / or amphoteric polymers in an amount of from 0.01 to 5% by weight, in particular in an amount of from 0.1 to 2% by weight, in each case based on the total application preparation.
  • Further preferred agents according to the invention are characterized in that they additionally care substance (s) - in terms of their weight - in amounts of 0.001 to 10 wt .-%, preferably 0.005 to 7.5 wt .-%, particularly preferably 0.01 to 5 Wt .-% and in particular 0.05 to 2.5 Wt .-%, with preferred care substance (s) are selected from the group L-carnitine and / or its salts; Panthenol and / or panthothenic acid; the 2-furanones and / or their derivatives (especially pantolactone); Taurine and / or its salts; niacinamide; ubiquinone; Ectoin; Allantoin.
  • preferred care substance (s) are selected from the group L-carnitine and / or its salts; Panthenol and / or panthothenic acid; the 2-furanones and / or their derivatives (especially pantolactone); Taurine and / or its salts; niaci
  • L-carnitine (IUPAC name (R) - (3-carboxy-2-hydroxypropyl) - A /, A /, A / -trimethylammonium hydroxide) is a naturally occurring, vitamin-like substance.
  • L-carnitine derivatives which are preferred according to the invention are selected in particular from acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and particularly preferably L-carnitine tartrate.
  • the L-carnitine compounds mentioned are available, for example, from Lonza GmbH (Wuppertal, Germany).
  • Preferred agents according to the invention are characterized in that they contain from -0.001 to 10% by weight, preferably 0.005 to 7.5% by weight, particularly preferably 0.01 to 5% by weight and in particular 0.05% by weight contain up to 2.5 wt .-% L-carnitine or L-carnitine derivatives, preferred L-carnitine derivatives are selected from acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and in particular L-carnitine tartrate.
  • Panthenol (IUPAC name: (+) - (R) -2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethylbutyramide) is converted to pantothenic acid in the body.
  • Pantothenic acid is a vitamin from the group of B vitamins (vitamin B5).
  • Preferred agents according to the invention are characterized in that they contain, based on their weight, from 0.01 to 5% by weight, preferably from 0.05 to 2.5% by weight, more preferably from 0.1 to 1.5% by weight. % and in particular 0.25 to 1 wt .-% of panthenol (( ⁇ ) -2,4-dihydroxy-A / - (3-hydroxypropyl) -3,3-dimethyl-butyramide).
  • taurine Another preferred care enhancer which has activating properties is taurine.
  • preferred means according to the invention contain - based on their weight - 0.01 to 15 wt .-%, preferably 0.025 to 12.5 wt .-%, particularly preferably 0.05 to 10% by weight, more preferably 0, 1 to 7 , 5 wt .-% and in particular 0.5 to 5 wt .-% taurine (2-aminoethanesulfonic acid).
  • compositions of the invention are vitamins, provitamins or vitamin precursors. These are described below:
  • agents according to the invention are preferred which, based on their weight, are from 0.1 to 5% by weight, preferably from 0.2 to 4% by weight, more preferably from 0.25 to 3.5% by weight, more preferably Contain 0.5 to 3 wt .-% and in particular 0.5 to 2.5 wt .-% vitamins and / or pro-vitamins and / or vitamin precursors, preferably the groups A, B, C, E, F and H.
  • vitamin B 5 2,4-dihydroxy-A / - (3-hydroxypropyl) -3,3-dimethylbutyramide, provitamin B 5 ) and / or pantothenic acid (vitamin B 3 , vitamin B 5 ) and / or Niacin, niacinamide or nicotinamide (vitamin B 3 ) and / or L-ascorbic acid (vitamin C) and / or thiamine (vitamin Bi) and / or riboflavin (vitamin B 2 , vitamin G) and / or biotin (vitamin B 7 , Vitamin H) and / or folic acid (Vitamin B 9 , Vitamin B c or Vitamin M) and / or Vitamin B 6 and / or Vitamin B-I2.
  • Certain quinones have particular suitability as a care enhancer.
  • Particularly preferred agents according to the invention are characterized in that they contain as care substance - based on their weight - 0.0001 to 1 wt .-%, preferably 0.001 to 0.5 wt .-% and particularly preferably 0.005 to 0.1 wt .-% containing at least one ubiquinone and / or at least one ubiquinol and / or at least one derivative of these substances, preferred agents containing a ubiquinone of the formula (Ubi)
  • n 6, 7, 8, 9 or 10, particularly preferably 10 (coenzyme Q10).
  • the agents according to the invention may contain ectoin.
  • Ectoine ((4S) -2-methyl-1, 4,5,6-tetrahydropyrimidine-4-carboxylic acid) is a natural product belonging to the group of compatible solutes.
  • the agents according to the invention may contain at least one carbohydrate from the group of monosaccharides, disaccharides and / or oligosaccharides.
  • preferred hair treatment compositions according to the invention characterized in that they are used as care substance - based on their weight - 0.01 to 5 wt .-%, preferably 0.05 to 4.5 wt .-%, particularly preferably 0.1 to 4 wt. -%, more preferably 0.5 to 3.5 wt .-% and in particular 0.75 to 2.5 wt .-% carbohydrate (s) selected from monosaccharides, disaccharides and / or oligosaccharides containing preferred carbohydrates are selected out
  • Monosaccharides in particular D-ribose and / or D-xylose and / or L-arabinose and / or D-glucose and / or D-mannose and / or D-galactose and / or D-fructose and / or sorbose and / or L-fucose and / or L-rhamnose
  • Disaccharides in particular sucrose and / or maltose and / or lactose and / or trehalose and / or cellobiose and / or gentiobiose and / or isomaltose.
  • the agents according to the invention may contain emulsifiers (F).
  • Emulsifiers effect at the phase interface the formation of water- or oil-stable adsorption layers, which protect the dispersed droplets against coalescence and thus stabilize the emulsion.
  • Emulsifiers are therefore constructed like surfactants from a hydrophobic and a hydrophilic part of the molecule. Hydrophilic emulsifiers preferably form O / W emulsions and hydrophobic emulsifiers preferably form W / O emulsions.
  • An emulsion is to be understood as meaning a droplet-like distribution (dispersion) of a liquid in another liquid under the expense of energy in order to create stabilizing phase interfaces by means of surfactants.
  • the selection of this emulsifying surfactants or emulsifiers depends on the substances to be dispersed and the respective outer phase and the fineness of the emulsion.
  • Emulsifiers which can be used according to the invention are, for example
  • Glucosides mixtures of alkyl (oligo) and fatty alcohols for example, the commercially available product ® Montanov 68,
  • Sterols are understood to mean a group of steroids which carry a hydroxyl group on C-atom 3 of the steroid skeleton and are isolated both from animal tissue (zoosterines) and from vegetable fats (phytosterols). Examples of zoosterols are cholesterol and lanosterol. Examples of suitable phytosterols are ergosterol, stigmasterol and sitosterol. Mushrooms and yeasts are also used to isolate sterols, the so-called mycosterols.
  • glucose phospholipids e.g. as lecithins or phosphatidylcholines from e.g. Egg yolk or plant seeds (e.g., soybeans) are understood.
  • Fatty acid esters of sugars and sugar alcohols such as sorbitol
  • Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hydroxystearate (commercial product Dehymuls ® PGPH),
  • Linear and branched fatty acids with 8 to 30 C atoms and their Na, K, ammonium, Ca, Mg and Zn salts.
  • the agents according to the invention preferably contain the emulsifiers in amounts of 0.1-25% by weight, in particular 0.5-15% by weight, based on the total agent.
  • the compositions according to the invention may preferably contain at least one nonionic emulsifier having an HLB value of 8 to 18.
  • Nonionic emulsifiers having an HLB value of 10 to 15 may be particularly preferred according to the invention.
  • cationic surfactants can be used, as described above as suitable care agents. With respect to the preferred cationic surfactants and the amounts used, the above statements apply accordingly.
  • the agents may contain other surfactants or emulsifiers, with both anionic and ampholytic and nonionic surfactants and all types of known emulsifiers being suitable in principle.
  • the group of ampholytic or amphoteric surfactants includes zwitterionic surfactants and ampholytes. The surfactants may already have emulsifying effect.
  • Suitable anionic surfactants are in principle all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. As a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule. Examples of suitable anionic surfactants are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts having 2 to 4 C atoms in the alkanol group,
  • Sulfosuccinic acid mono- and dialkyl esters having 8 to 24 C atoms in the alkyl group and sulfosuccinic acid monoalkylpolyoxyethyl esters having 8 to 24 C atoms in the alkyl group and 1 to 6 oxyethyl groups,
  • Alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 carbon atoms are alpha-sulfofatty acids having 8 to 30 carbon atoms.
  • Alkyl sulfates and alkyl polyglycol ether sulfates of the formula R-O (CH 2 -CH 2 O) x -OSO 3 H, in which R is a preferably linear alkyl group having 8 to 30 C atoms and x 0 or 1 to 12,
  • esters of tartaric acid and citric acid with alcohols which are adducts of about 2-15 molecules of ethylene oxide and / or propylene oxide with fatty alcohols having 8 to 22 C atoms,
  • R 7 CO- for a linear or branched, aliphatic, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms, Alk for CH 2 CH 2 , CHCH 3 CH 2 and / or CH 2 CHCH 3 , n for numbers from 0.5 to 5 and M is a cation, as described in DE-OS 197 36 906,
  • Condensation products of C 8 - C 30 - fatty alcohols with protein hydrolysates and / or amino acids and their derivatives which are known to the skilled person as protein fatty acid condensates, such as Lamepon ® - types Gluadin ® - types Hostapon ® KCG or Amisoft ® - types.
  • Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids having 10 to 18 carbon atoms in the alkyl group and up to 12 glycol ether groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having 8 to 18 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethylester with 8 to 18 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, Monoglycerdisulfate, alkyl and Alkenyletherphosphate and Eiweissfettkladensate.
  • Zwitterionic surfactants are surface-active compounds which contain at least one quaternary ammonium group and at least one -COO ⁇ _) in the molecule - carry S0 3 ⁇ _) group - or.
  • Particularly suitable zwitterionic surfactants are the so-called betaines, such as the N-alkyl-N, N-dimethylammonium glycinates, for example the cocoalkyldimethylammoniumglycinate, N-acylaminopropyl-N, N-dimethylammoniumglycinate, for example the cocoacylaminopropyldimethylammoniumglycinate, and 2-alkyl-3-carboxymethyl-3-hydroxyethyl-imidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group, and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • a preferred zwitterionic surfactant is the fatty
  • Ampholytes are understood as meaning those surface-active compounds which, apart from a C 8 -C 24 -alkyl or -acyl group in the molecule, contain at least one free amino group and at least one -COOH or -SO 3 H group and are capable of forming internal salts.
  • ampholytes are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each having about 8 to 24 C atoms in the alkyl group.
  • Particularly preferred ampholytes are alkylaminopropionate the N-coconut, cocoacylaminoethylaminopropionate and C12 - C 8 - sarcosine.
  • Nonionic surfactants contain, for example, a polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether group as the hydrophilic group. Such compounds are, for example,
  • R is CO for a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms
  • R 2 is hydrogen or methyl
  • R 3 is linear or branched alkyl radicals having 1 to 4 carbon atoms
  • w is a number from 1 to 20 .
  • R 4 is an alkyl or alkenyl radical having 4 to 22 carbon atoms
  • G is a sugar radical having 5 or 6 carbon atoms
  • p is a number from 1 to 10. They can be obtained by the relevant methods of preparative organic chemistry.
  • the preferred alkyl and / or alkenyl oligoglycosides are thus alkyl and / or alkenyl oligoglucosides.
  • the index number p in the general formula (E4-II) indicates the degree of oligomerization (DP), ie the distribution of mono- and oligoglycosides, and represents a number between 1 and 10.
  • the alkyl or alkenyl radical R 4 can be derived from primary Derive alcohols with 4 to 1 1, preferably 8 to 10 carbon atoms. Preference is given to alkyl oligoglucosides based on hydrogenated C 12/14 coconut alcohol having a DP of 1 to 3.
  • the preferred nonionic surfactants are the alkylene oxide addition products of saturated linear fatty alcohols and fatty acids having in each case 2 to 30 moles of ethylene oxide per mole of fatty alcohol or fatty acid. Preparations having excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants. These connections are identified by the following parameters.
  • the alkyl radical R contains 6 to 22 carbon atoms and may be both linear and branched. Preference is given to primary linear and methyl-branched in the 2-position aliphatic radicals.
  • Such alkyl radicals are, for example, 1-octyl, 1-decyl, 1-lauryl, 1-myristyl, 1-cetyl and 1-stearyl. Particularly preferred are 1-octyl, 1-decyl, 1-lauryl, 1-myristyl.
  • oxo-alcohols compounds with an odd number of carbon atoms in the alkyl chain predominate.
  • the compounds used as surfactant with alkyl groups may each be uniform substances. However, it is generally preferred to use native vegetable or animal raw materials in the production of these substances, so that substance mixtures having different alkyl chain lengths depending on the respective raw material are obtained.
  • the other surfactants are usually in amounts of 0, 1 to 45 wt .-%, preferably 0.5 to 30 wt .-% and most preferably from 0.5 to 25 wt .-%, based on the respective total Composition, used.
  • the amount used depends essentially on the purpose of the agent according to the invention. If it is a shampoo or other cleansing agent, surfactant levels above 45% by weight are also common.
  • compositions according to the invention can be carried out in all forms customary for cosmetic compositions, for example in the form of solutions which can be applied to the skin or hair as facial or hair tonic or pump or aerosol spray, in the form of creams, emulsions, waxes , Gels or surfactant-containing foaming solutions or other preparations which are suitable for use on the skin or hair.
  • Very particularly preferred agents according to the invention are characterized in that they are a styling gel, a styling cream, a styling wax, a pump hair spray, an aerosol hair spray, a pump hair foam, an aerosol hair foam or combinations thereof.
  • the agents of the invention are means for temporarily deforming keratinic fibers, i. to styling agent.
  • Preferred styling agents are styling gels, pump hair sprays, aerosol hair spray, pumped hair foams and aerosol hair foams.
  • Styling gel is in the context of the present application, the generic term for clear or cloudy products, styling waxes, styling creams, styling lotions, styling jellies, etc. Ultimately, this term covers all means for hairdressing hair, which are not hair sprays or foams.
  • Hair foams are understood to mean compositions which form a foam when they are removed from a suitable container. It may be necessary to the means Add ingredients that promote foaming or stabilize foam once formed.
  • surfactants and / or emulsifiers are suitable for this, as have already been described above.
  • surfactants from the group of cationic surfactants are used.
  • Hair creams and gels generally contain structurants and / or thickening polymers which serve to give the products the desired consistency.
  • Structurants and / or thickening polymers are typically used in an amount of from 0.1 to 10% by weight, based on the total product. Amounts of 0.5 to 5 wt .-%, in particular 0.5 to 3 wt .-% are preferred.
  • the polymer combination used according to the invention has self-thickening properties, the addition of further structural and / or thickening polymers is not absolutely necessary.
  • the agents according to the invention preferably contain no further structuring agents and / or thickening polymers.
  • Propellants suitable according to the invention are, for example, N 2 O, dimethyl ether, CO 2 , air and alkanes having 3 to 5 carbon atoms, such as propane, n-butane, isobutane, n-pentane and isopentane, and mixtures thereof.
  • propane, n-butane, isobutane, n-pentane and isopentane and mixtures thereof.
  • the alkanes mentioned, mixtures of said alkanes or mixtures of said alkanes with dimethyl ether are used as the sole blowing agent.
  • the invention expressly also includes the concomitant use of propellants of the type of chlorofluorocarbons, but in particular of fluorocarbons.
  • propellants of the type of chlorofluorocarbons, but in particular of fluorocarbons.
  • the sizes of the aerosol droplets or of the foam bubbles and the respective size distribution can be set for a given spraying device.
  • blowing agent used varies depending on the specific composition of the composition, the packaging used and the desired product type, such as hair spray or hair foam.
  • aerosol foam products preferably contain the blowing agent in amounts of from 1 to 35% by weight, based on the total product. Amounts of 2 to 30 wt .-%, in particular from 3 to 15 wt .-% are particularly preferred. Aerosol sprays generally contain larger amounts of propellant.
  • the blowing agent is used in this case in an amount of 30 to 98 wt .-%, based on the total product. Amounts of 40 to 95 wt .-%, in particular from 50 to 95 wt .-% are particularly preferred.
  • the aerosol products can be prepared in the usual way.
  • all constituents of the respective agent with the exception of the propellant, are introduced into a suitable pressure-resistant container. This is then closed with a valve.
  • the desired amount of blowing agent is introduced.
  • a second subject of the invention is therefore a process for the temporary deformation of keratinous fibers, in which the cosmetic agent according to the invention is applied to the hair Applied with the hair and / or fingers,
  • a third object of the invention is the use of the means according to the invention for the temporary deformation of keratinous fibers.
  • the compositions according to the invention and products which contain these agents are distinguished in particular by the fact that they give treated hair a very strong hairstyle hold, without rendering the hair brittle or inflexible. Rather, a pleasant, soft grip is achieved.
  • compositions according to the invention can be carried out in all forms customary for cosmetic compositions, for example in the form of solutions which can be applied to the skin or hair as facial or hair tonic or pump or aerosol spray, in the form of creams, emulsions, waxes , Gels or surfactant-containing foaming solutions or other preparations which are suitable for use on the skin or hair.
  • the styling agents E1 to E4 according to the invention were prepared according to Table 1 below.
  • compositions were prepared by conventional mixing of the raw materials listed in the table and used by rubbing on the palms and subsequent application to dry or damp hair hair styling.
  • the hair had a soft shine, excellent hairstyle hold and an excellent Remodulieriana.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Insects & Arthropods (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des produits de coiffage qui contiennent, dans un véhicule cosmétiquement acceptable, en % en poids rapportés respectivement à leur poids, de 0,01 à 3 % en poids d'au moins un copolymère A, qui comprend au moins un motif structural de formule (I) et au moins un motif structural de formule (II), dans laquelle X+ représente un cation physiologiquement acceptable, et de 0,05 à 10 % en poids, de préférence de 0,1 à 7,5 % en poids, ou mieux encore de 0,25 à 6 % en poids et plus particulièrement de 0,5 à 5 % en poids d'au moins un polymère filmogène, et de 0,5 à 30 % en poids, de préférence de 1 à 25 % en poids, mieux encore de 2,5 à 20 % en poids et plus particulièrement de 5 à 15 % en poids d'au moins une cire dont le point de fusion se situe dans une plage de 40°C à 90°C. Ces produits de coiffage présentent un pouvoir fixant élevé, et confèrent un effet soignant agréable et ne produisent pas d'effet alourdissant.
EP12724336.8A 2011-06-08 2012-05-30 Produit de coiffage sans effet alourdissant Ceased EP2717847A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102011077233A DE102011077233A1 (de) 2011-06-08 2011-06-08 nicht beschwerendes Stylingmittel
PCT/EP2012/060131 WO2012168120A2 (fr) 2011-06-08 2012-05-30 Produit de coiffage sans effet alourdissant

Publications (1)

Publication Number Publication Date
EP2717847A2 true EP2717847A2 (fr) 2014-04-16

Family

ID=46178553

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12724336.8A Ceased EP2717847A2 (fr) 2011-06-08 2012-05-30 Produit de coiffage sans effet alourdissant

Country Status (4)

Country Link
US (1) US20140099275A1 (fr)
EP (1) EP2717847A2 (fr)
DE (1) DE102011077233A1 (fr)
WO (1) WO2012168120A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013204685A1 (de) * 2013-03-18 2014-10-02 Beiersdorf Ag Haarstylingemulsion
DE102013204683A1 (de) * 2013-03-18 2014-09-18 Beiersdorf Ag Haarstylingemulsion
EP3275425B1 (fr) * 2016-07-26 2021-03-03 Kao Germany GmbH Composition de coiffure
DE102016225873A1 (de) * 2016-12-21 2018-06-21 Henkel Ag & Co. Kgaa Mittel und Verfahren zur temporären Verformung keratinhaltiger Fasern

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011076566A1 (fr) * 2009-12-23 2011-06-30 Henkel Ag & Co. Kgaa Émulsion pour fibres kératiniques, contenant au moins un polymère anionique à effet épaississant, au moins un polymère non ionique fixant les cheveux, au moins une huile-ester, au moins une cire et de l'eau

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19736C (fr)
LU87457A1 (fr) * 1989-02-24 1990-09-19 Oreal Utilisation,comme composition cosmetique pour cheveux,d'une microdispersion de cire,et procede de traitement des cheveux avec une telle composition
DE4413686C2 (de) 1994-04-20 1996-10-24 Henkel Kgaa Kationische Zuckertenside, Verfahren zu ihrer Herstellung und deren Verwendung
DE19736906A1 (de) 1997-08-25 1999-03-04 Henkel Kgaa Verfahren zur Herstellung von sulfatierten Fettsäurealkylenglykolestern
DE19949382A1 (de) * 1999-10-13 2001-04-19 Basf Ag Verwendung feinteiliger, farbstoffhaltiger Polymerisate PF als farbgebenden Bestandteil in kosmetischen Mitteln
EP1269974A1 (fr) * 2001-06-18 2003-01-02 Unilever Plc Compositions de coiffage
US6905674B2 (en) * 2003-04-14 2005-06-14 L'oreal Aqueous photoprotective compositions comprising acrylamido-2-methylpropanesulfonic acid polymers and 4,4-diarylbutadiene UV-A sunscreens
JP4210614B2 (ja) * 2004-03-25 2009-01-21 花王株式会社 毛髪化粧料
US20050249684A1 (en) * 2004-05-07 2005-11-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Taurate formulated pigmented cosmetic composition exhibiting radiance with soft focus
FR2876280B1 (fr) * 2004-10-13 2008-03-21 Oreal Composition cosmetique pour le soin et/ou le maquillage, resistante a l'eau, comprenant au moins un latex ou un pseudo-latex et facilement demaquillable
JP2008156326A (ja) * 2006-12-26 2008-07-10 Shiseido Co Ltd 化粧料
JP2008255023A (ja) * 2007-04-02 2008-10-23 Kao Corp 皮膚外用剤
DE102008016065A1 (de) * 2008-03-25 2009-10-01 Beiersdorf Ag Stylingformulierung zur Erstellung eines flexiblen Haltes durch Einsatz bestimmter Wachse
FR2930144A1 (fr) * 2008-04-18 2009-10-23 Oreal Vernis a ongles sous forme d'emulsion, comprenant un agent gelifiant particulier
DE102008034102A1 (de) * 2008-07-21 2010-01-28 Henkel Ag & Co. Kgaa Geschmeidiges Stylingmittel mit hohem Haltegrad

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011076566A1 (fr) * 2009-12-23 2011-06-30 Henkel Ag & Co. Kgaa Émulsion pour fibres kératiniques, contenant au moins un polymère anionique à effet épaississant, au moins un polymère non ionique fixant les cheveux, au moins une huile-ester, au moins une cire et de l'eau

Also Published As

Publication number Publication date
WO2012168120A3 (fr) 2013-02-07
WO2012168120A2 (fr) 2012-12-13
DE102011077233A1 (de) 2012-12-13
US20140099275A1 (en) 2014-04-10

Similar Documents

Publication Publication Date Title
EP2717845B1 (fr) Agent de mise en forme à tenue maximale
EP2211832B1 (fr) Agents de traitement capillaire, notamment produits coiffants, contenant deux copolymères
EP2717843B1 (fr) Produits coiffants à texture intéressante
EP2515839A1 (fr) Émulsion pour fibres kératiniques, contenant au moins un polymère anionique à effet épaississant, au moins un polymère non ionique fixant les cheveux, au moins une huile-ester, au moins une cire et de l'eau
DE102015222976A1 (de) Haarpflegemittel enthaltend Caseinhydrolysat zur Verbesserung der Haarstruktur
EP2717847A2 (fr) Produit de coiffage sans effet alourdissant
EP2054025B1 (fr) Agent fixant pour fibres de kératine
EP2272499B1 (fr) Produits de coiffage apportant une tenue forte en atmosphère humide
DE102009020552A1 (de) Polymerkombination aus mindestens zwei verschiedenen N-Vinylpyrrolidon/N-Vinylcaprolactam-Copolymeren für glanzgebende kosmetische Haarbehandlungsmittel
EP2054024B1 (fr) Produit coiffant assurant une tenue forte
EP2489345B1 (fr) Produits de coiffage apportant une tenue forte en atmosphère humide III
WO2011047941A2 (fr) Produit cosmétique pour dompter les cheveux rebelles et trop frisés
EP2437853A2 (fr) Produit cosmétique de nettoyage tensioactif contenant de la gelée royale
EP2448547A2 (fr) Spray capillaire compact
DE10258394A1 (de) Tücher zur Pflege keratinischer Fasern
DE102013225609A1 (de) Haarreinigungsmittel mit interessanter Textur
EP1569605B1 (fr) Etoffes de nettoyage pour nettoyer des fibres de keratine
DE102007037429A1 (de) Stylingmittel auf Basis wässriger Silicondispersionen
WO2013083354A1 (fr) Produits d'hygiène capillaire à texture intéressante
WO2013083353A1 (fr) Produits de soin capillaire à texture intéressante
EP1669109A1 (fr) Compositions de conditionnement des cheveux contenant des substances réducteurs de la kératine
DE102009002538A1 (de) Dauerwellmittel und Haarverformungsverfahren für moderne Frisuren
EP2626062A2 (fr) Agent cosmétique contenant du (C8 à C20)-alcane, du diméthylpolysiloxane, du diméthyconol et au moins une matière active à action renforçatrice

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20131107

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20150513

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20170403